MarketInOut Stock Screener Log In | Sign Up

Aarti Pharmalabs Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Aarti Pharmalabs Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization84,110 mln
Float51.01 mln
Earnings Date02/10/2027

EPS

23.50
Exceptional

P / E

37.11
Overvalued

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.16
Caution advised

Relative Strength

79 / 100
Strongly outperforming

Debt / Equity

0.36
Low leverage

Business Description

Aarti Pharmalabs Limited is a Mumbai-based pharmaceutical company that produces and sells active drug ingredients, chemical intermediates, and specialty compounds like caffeine and theophylline to customers in India and around the world. The company serves a broad range of medical needs, from heart and diabetes treatments to cancer and eye care medications. It also manufactures industrial chemicals and offers contract services to help other companies develop and produce drug substances.

Key Fundamentals

EPS23.50
P/E37.11
ROE9.54
RPS217
ROIC8.35
ROA6.08
Interest Cover6.19
EBITDA, mln4,317
EV / EBITDA20.21
EV / EBIT27.25
Revenue, mln19,690
EV / Revenue4.43

Quote Details

Last 872.00
Change -55.55 (-5.99%)
Open 938.00
Volume 38,275
Turnover 33,375,802
Average Volume 42,610

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio1.49
Price / Book3.75
Price / Tangible Book3.99
Price / Cash Flow84.41
Debt / Equity0.36
Price / Sales4.05

Financial Strength

Altman Z-Score5.12
Piotroski F-Score 3 / 9
Beneish M-Score-2.16
Price to Graham Number2.76

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.94% 83 / 100   
1 Month -10.41% 33 / 100   
2 Months 32.5% 93 / 100   
6 Months 23.09% 84 / 100   
1 Year 3.25% 75 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog